Migraine Newswire (Page 3)

Migraine Newswire (Page 3)

Comprehensive Real-Time News Feed for Migraine. (Page 3)

Results 41 - 60 of 264 in Migraine

  1. Vernalis plc (LON:VER) Receives Consensus Recommendation of "Buy" from BrokeragesRead the original story w/Photo

    Jul 11, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  2. Vernalis plc (VER) Given house stock Rating at Shore CapitalRead the original story w/Photo

    Jul 11, 2016 | Daily Political

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  3. Vernalis plc (VER) Earns "Buy" Rating from Panmure GordonRead the original story w/Photo

    Jul 8, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  4. RedHill Biopharma Ltd - (RDHL) Rating Lowered to Hold at Zacks Investment ResearchRead the original story w/Photo

    Jul 8, 2016 | Daily Political

    According to Zacks, "RedHill Biopharma is an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer.

    Comment?

  5. Canaccord Genuity Reaffirms Buy Rating for Vernalis plcRead the original story w/Photo

    Jul 8, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  6. Vernalis plc (VER) Receives " House Stock" Rating from Shore CapitalRead the original story w/Photo

    Jul 8, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  7. RedHill Biopharma and IntelGenx announce definitive agreement for...Read the original story w/Photo

    Jul 6, 2016 | Medical News

    ... of experience in the research, development and commercialization of proprietary pharmaceutical products, including migraine and other central nervous system (CNS) drugs, in Europe, Latin America and other territories. Under the terms of the ...

    Comment?

  8. RedHill Biopharma Ltd - (RDHL) Downgraded to Hold at Zacks Investment ResearchRead the original story w/Photo

    Jul 6, 2016 | AmericanBankingNews.com

    According to Zacks, "RedHill Biopharma is an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer.

    Comment?

  9. GSK migraine simulator demonstrates AR/VR potential for healthcare marketingRead the original story w/Photo

    Jul 5, 2016 | Econsultancy

    ... of augmented reality (AR) and virtual reality (VR) technology. According to GSK, which manufactures Excedrin Migraine medication, more than 36m people in the US alone suffer from migraine headaches, but those who don't often struggle to understand ...

    Comment?

  10. IntelGenx and RedHill Biopharma Announce Signing of Definitive...Read the original story w/Photo

    Jul 5, 2016 | Market Wire

    ... of experience in the research, development and commercialization of proprietary pharmaceutical products, including migraine and other central nervous system (CNS) drugs, in Europe, Latin America and other territories. According to the definitive ...

    Comment?

  11. People With Migraines Are Found To Have Deficiencies In Vitamin DRead the original story

    Jul 2, 2016 | Lifehack.org

    If you suffer from migraines or know someone who does you are not alone. The Migraine Research Foundation estimates that around 38 million people in the United States alone and 1 billion people around the world suffer from these painful headaches.

    Comment?

  12. Vernalis plc (VER) Stock Rating Reaffirmed by Stifel NicolausRead the original story w/Photo

    Jun 29, 2016 | Daily Political

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  13. RedHill Biopharma Ltd - (RDHL) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Jun 28, 2016 | AmericanBankingNews.com

    The brokerage presently has a $11.00 price objective on the stock. Zacks Investment Research's price objective indicates a potential upside of 9.78% from the stock's current price.

    Comment?

  14. Teva launches generic version of Glaxo's migraine med Imitrex in U.S.Read the original story w/Photo

    Jun 27, 2016 | Seeking Alpha

    Teva Pharmaceutical Industries launches its generic equivalent of GlaxoSmithKline's Imitrex in the U.S. for the treatment of acute migraine, with or without aura, and acute cluster headaches in adults.

    Comment?

  15. Teva and Antares Pharma Announce Launch of Generic Imitrex in the United StatesRead the original story w/Photo

    Jun 27, 2016 | Freshnews

    Teva Pharmaceutical Industries Ltd., and Antares Pharma, Inc. today announced the launch of the generic equivalent to ImitrexA 1 injection, 4 mg and 6 mg single-dose, prefilled syringe autoinjectors, in the U.S. Sumatriptan injection is used to treat acute migraine with or without aura, and acute cluster headaches in adults. Sumatriptan injection is self-administered subcutaneously into the back of arm or outer thigh.

    Comment?

  16. Researchers pinpoint best meds to treat migraine in the emergency departmentRead the original story w/Photo

    Jun 27, 2016 | Fox News

    New guidelines for doctors will help them treat migraine headaches that are severe enough to bring patients to the emergency department. According to the guidelines, emergency physicians should avoid injecting migraine patients with morphine or morphine-like drugs , known as opioids.

    Comment?

  17. NYU Langone Medical Center Researchers Pinpoint Best Meds To Treat Migraine In The EDRead the original story

    Jun 26, 2016 | BioSpace

    New guidelines for doctors will help them treat migraine headaches that are severe enough to bring patients to the emergency department. According to the guidelines, emergency physicians should avoid injecting migraine patients with morphine or morphine-like drugs, known as opioids.

    Comment?

  18. Stifel Nicolaus Reaffirms "Buy" Rating for Vernalis plcRead the original story w/Photo

    Jun 25, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  19. Vernalis plc (VNLPY) Stock Rating Reaffirmed by Stifel NicolausRead the original story w/Photo

    Jun 25, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  20. Researchers pinpoint best meds to treat migraine in the EDRead the original story w/Photo

    Jun 24, 2016 | Reuters

    New guidelines for doctors will help them treat migraine headaches that are severe enough to bring patients to the emergency department. According to the guidelines, emergency physicians should avoid injecting migraine patients with morphine or morphine-like drugs, known as opioids.

    Comment?